Weight Management Is a Serious Health Matter
Obesity is recognized by the World Health Organization as a chronic disease.1 Although GLP-1-based medications are highly sought after, FastMed emphasizes that these are prescription drugs. Inappropriate use may lead to serious side effects.
The platform has observed numerous informal channels selling weight-loss injections locally. Members of the public who use these without proper medical assessment may not only experience limited effectiveness but also face potential health risks. FastMed is committed to providing medical services, not merely “selling medications,” aiming to offer the public access to proper medical advice through regulated online channels and to reduce the circulation of non-compliant or counterfeit drugs.
Three-Step Safety Protocol: Consultation, Prescription & Delivery
Unlike conventional e-commerce platforms, FastMed’s weight management program follows a strict medical process:
Technology Makes Professional Healthcare More Accessible
Through FastMed’s integrated platform, users can access medical services equivalent to in-clinic standards without needing to visit in person. The process is designed to be highly private, helping individuals manage their health in a medically supervised, safe, and convenient manner.
Learn more: Weight Management Project | GLP-1 Treatment Plan
The medications mentioned are prescription-only. Effectiveness and side effects vary. A clinical assessment by a registered doctor is required to determine suitability. Do not purchase or use without medical supervision.
Hashtag: #FastMed #Medical #Health
The issuer is solely responsible for the content of this announcement.
FastMed is an innovative telemedicine and online dispensing platform based in Hong Kong, providing convenient, efficient, and safe online consultation and medication delivery services.
For more information, visit:
Get ready, Malaysia! Plug & Play 5g advanced home WiFi with premium streaming has now…
JAKARTA, INDONESIA - Media OutReach Newswire – 19 December 2025 – At the Kumparan Awards:…
SINGAPORE - Media OutReach Newswire - 19 December 2025 – As hiring expectations continue to…
TOKYO, JAPAN - Media OutReach Newswire - 19 December 2025 – Exein, the European leader…
SEOUL, SOUTH KOREA - Media OutReach Newswire - 19 December 2025 – Exein, the European…
BANGKOK, THAILAND - Media OutReach Newswire - 19 December 2025 - Following the recent tablets…